Dicerna Pharmaceuticals Total Assets 2012-2021 | DRNA

Dicerna Pharmaceuticals total assets from 2012 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Dicerna Pharmaceuticals Annual Total Assets
(Millions of US $)
2020 $708
2019 $597
2018 $409
2017 $121
2016 $51
2015 $100
2014 $104
2013 $50
2012 $10
2011 $25
Dicerna Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2021-09-30 $772
2021-06-30 $838
2021-03-31 $683
2020-12-31 $708
2020-09-30 $682
2020-06-30 $732
2020-03-31 $779
2019-12-31 $597
2019-09-30 $336
2019-06-30 $361
2019-03-31 $384
2018-12-31 $409
2018-09-30 $186
2018-06-30 $90
2018-03-31 $104
2017-12-31 $121
2017-09-30 $83
2017-06-30 $95
2017-03-31 $39
2016-12-31 $51
2016-09-30 $63
2016-06-30 $74
2016-03-31 $86
2015-12-31 $100
2015-09-30 $114
2015-06-30 $128
2015-03-31 $93
2014-12-31 $104
2014-09-30 $116
2014-06-30 $124
2014-03-31 $136
2013-12-31 $50
2013-09-30 $56
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2011-12-31 $25
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.977B $0.164B
Dicerna Pharmaceuticals, Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its proprietary RNA interference technology platform primarily in the United States and internationally. Dicerna Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $121.969B 7.71
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.359B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $7.214B 0.00
Arcus Biosciences (RCUS) United States $3.030B 0.00
Emergent Biosolutions (EBS) United States $2.347B 8.44
ADC Therapeutics SA (ADCT) Switzerland $1.505B 0.00
Myovant Sciences (MYOV) United Kingdom $1.429B 0.00
Zymeworks (ZYME) Canada $0.942B 0.00
Ambrx Biopharma (AMAM) United States $0.366B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.09